Back to Search
TAMARA BAVENDAM, M.D.
M.D.
Urology Physician
NPI: 1982845087Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
MD061573L(PA)
Research & Publications (20)
Overactive bladder and women's sexual health: what is the impact?
PMID 17498103·J Sex Med·2007
4-observational
Evaluating the impact of overactive bladder on sexual health in women: what is relevant?
PMID 17034411·J Sex Med·2007
8-other
The psychometric validation of the OAB family impact measure (OAB-FIM).
PMID 19274760·Neurourol Urodyn·2010
4-observational
Efficacy and tolerability of fesoterodine in women with overactive bladder.
PMID 19495545·Int Urogynecol J Pelvic Floor Dysfunct·2009
4-observational
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
PMID 19601704·Curr Med Res Opin·2009
4-observational
Bother related to bladder control and health care seeking behavior in adults in the United States.
PMID 19375096·J Urol·2009
8-other
Challenges for managing overactive bladder and guidance for patient support.
PMID 19355801·Am J Manag Care·2009
8-other
Combined effects of behavioral intervention and tolterodine in patients dissatisfied with overactive bladder medication.
PMID 19375110·J Urol·2009
4-observational
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
PMID 18583022·Eur Urol·2009
8-other
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
PMID 18510659·BJU Int·2008
4-observational
Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
PMID 18817961·Urology·2008
2-rct
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women.
PMID 18685795·Int Urogynecol J Pelvic Floor Dysfunct·2008
4-observational
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
PMID 18639297·J Urol·2008
2-rct
The responsiveness of the OAB-q among OAB patient subgroups.
PMID 17016794·Neurourol Urodyn·2007
4-observational
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
PMID 17937959·J Urol·2007
4-observational
Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial.
PMID 17284249·BJOG·2007
4-observational
Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial.
PMID 16805764·Int J Clin Pract·2006
3-trial
Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia.
PMID 16686723·BJU Int·2006
4-observational
Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial.
PMID 16805763·Int J Clin Pract·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 235 E 42ND ST, 235/4/46
NEW YORK, NY 10017 - Phone
- (212) 733-3936
Quick Facts
- NPI
- 1982845087
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile